Siga Technologies Sees Unusually High Options Volume (NASDAQ:SIGA)

Siga Technologies Inc. (NASDAQ:SIGA) was the recipient of unusually large options trading on Wednesday. Stock investors acquired 1,200 call options on the company. This represents an increase of 1,438% compared to the typical daily volume of 78 call options.

Siga Technologies Price Performance

SIGA opened at $6.25 on Thursday. Siga Technologies has a 52 week low of $4.95 and a 52 week high of $9.62. The stock has a market cap of $447.56 million, a PE ratio of 6.13 and a beta of 0.98. The business has a 50 day moving average of $7.28 and a 200-day moving average of $7.43.

Siga Technologies (NASDAQ:SIGA) last posted its quarterly earnings data on Thursday, November 6th. The company reported ($0.09) earnings per share (EPS) for the quarter. The firm had revenue of $2.62 million during the quarter. Siga Technologies had a return on equity of 35.23% and a net margin of 43.22%. Equities analysts anticipate that Siga Technologies will post 1.04 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the business. CIBC Bancorp USA Inc. purchased a new position in Siga Technologies during the 3rd quarter valued at about $235,000. Jacobs Levy Equity Management Inc. increased its stake in shares of Siga Technologies by 5.7% during the third quarter. Jacobs Levy Equity Management Inc. now owns 463,705 shares of the company’s stock valued at $4,243,000 after purchasing an additional 24,851 shares in the last quarter. PharVision Advisers LLC purchased a new position in shares of Siga Technologies during the third quarter valued at approximately $138,000. Sherbrooke Park Advisers LLC bought a new stake in shares of Siga Technologies in the 3rd quarter worth approximately $125,000. Finally, Qube Research & Technologies Ltd bought a new stake in shares of Siga Technologies in the 3rd quarter worth approximately $423,000. 55.40% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages recently commented on SIGA. Weiss Ratings restated a “hold (c-)” rating on shares of Siga Technologies in a report on Monday. Wall Street Zen lowered shares of Siga Technologies from a “strong-buy” rating to a “hold” rating in a report on Saturday, November 15th. One research analyst has rated the stock with a Hold rating, According to MarketBeat, Siga Technologies presently has an average rating of “Hold”.

Siga Technologies Company Profile

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.